Literature DB >> 15081664

Effect of methylprednisolone in patients with Guillain-Barré syndrome.

Keiichiro Susuki, Nobuhiro Yuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081664     DOI: 10.1016/S0140-6736(04)15962-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India.

Authors:  Priyank Patel; Darshil Shah; Chinmay Jani; Irmgard Behlau; Ami Parikh; Jui Shah; Ruchi Jani; Arjun Kelaiya; Jinal Pandya; Harpreet Singh; Omar Al Omari; Dhara Roy
Journal:  BMC Neurol       Date:  2022-04-22       Impact factor: 2.903

2.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

3.  Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome.

Authors:  Nandagopal Nithyashree; Madhuram Dhanaraj; Senthil Kumar; M B Saraswathi
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

4.  A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain-Barre Syndrome.

Authors:  Rahi Kiran Bhattiprolu; Vijay Sardana; Dilip Maheshwari; Bharat Bhushan; Prashant Shringi; Pallav Jain; Vaishal Shah; Bhavin Patel
Journal:  Ann Indian Acad Neurol       Date:  2020-01-21       Impact factor: 1.383

5.  Short-Term Prognosis of Mechanically Ventilated Patients With Guillain-Barré Syndrome Is Worsened by Corticosteroids as an Add-On Therapy.

Authors:  Xiujuan Wu; Bing Zhang; Chunrong Li; Donghui Shen; Kangding Liu; Jie Zhu; Hong-Liang Zhang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.